Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
申请人:——
公开号:US20030229120A1
公开(公告)日:2003-12-11
Novel ligands for the HisB10 Zn
2+
sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.
The present invention provides pharmaceutical compositions comprising insulin and novel ligands for the His
B10
Zn
2+
sites of the R-state insulin hexamer. The resulting preparations have improved physical and chemical stability.
[EN] PHARMACEUTICAL PREPARATIONS COMPRISING ACID-STABILISED INSULIN<br/>[FR] PREPARATIONS PHARMACEUTIQUES CONTENANT DE L'INSULINE STABILISEE D'UN POINT DE VUE ACIDE
申请人:NOVO NORDISK AS
公开号:WO2004080480A1
公开(公告)日:2004-09-23
Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.
[3+2] Cycloaddition Reactions in the Solid-Phase Synthesis of 1,2,3-Triazoles
作者:Yongnian Gao、Yulin Lam
DOI:10.1021/ol0611494
日期:2006.7.1
[Structure: see text] An efficient and regioselective procedure for the synthesis of 1,2,3-triazoles via a [3+2] cycloaddition of polymer-bound vinyl sulfone and sodium azide is described. Microwave irradiation provided significant rate enhancement in all steps of the three-step protocol. A representative set of 23 compounds was prepared.
Novel ligands for the HisB10 Zn
2+
sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.